Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model
Hyunsoo Chung(Seoul National University), Chae Yoon Chon(Yonsei University Health System), Sang Kil Lee(Korea Advanced Institute of Science and Technology), Seung Up Kim(Yonsei University), Kyu Sik Jung(Yonsei University), Young Eun Chon(Yonsei University), Kwang‐Hyub Han(Yonsei University)
Cited by 3
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789